Progress in Neuro-Psychopharmacology and Biological Psychiatry

Titel Veröffentlichungsdatum Sprache Zitate
PSD95: A synaptic protein implicated in schizophrenia or autism?2018/03/01English186
The combined dexamethasone/CRH test as a potential surrogate marker in depression2005/07/01English186
Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects2009/08/01English183
Adolescent development, hypothalamic-pituitary-adrenal function, and programming of adult learning and memory2010/06/01English181
Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine2010/08/01English178
Homocysteine and folate metabolism in depression2005/09/01English177
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia2004/03/01English175
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview2007/01/01English175
Animal behavior models of the mechanisms underlying antipsychotic atypicality2003/10/01English175
The measurement of suicidality, aggressivity and impulsivity1989/01/01English174
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats2009/04/01English174
Pharmacological analysis of zebrafish (Danio rerio) scototaxis2011/03/01English173
Voxelwise meta-analysis of gray matter reduction in major depressive disorder2012/01/01English172
Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models2011/08/01English171
Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil1988/01/01English171
Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis2018/06/01English170
Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression2009/11/01English168
Steroids, neuroactive steroids and neurosteroids in psychopathology2005/02/01English164
Adverse effects of cannabis on health: an update of the literature since 19962004/08/01English163
The silent epidemic of chronic pain in older adults2019/07/01English163
The prevalence of anxiety and depression among healthcare workers during the COVID-19 pandemic: An umbrella review of meta-analyses2021/04/01English159
Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment2013/08/01English159
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis2014/01/01English159
Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia2008/10/01English156
Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids2010/06/01English155
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings2006/08/01English150
Cytokines and serotonin transporter in patients with major depression2006/07/01English149
Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women2006/09/01English149
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study2012/06/01English149
Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression2013/07/01English149